Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EASY

Financiado

Cerrado

Epigenetic approach for the treatment of obesity

It has been estimated a threefold increase in the number of obese people in Europe since the 1980’s. Currently, EU countries spend an average of 7% of their public health budgets on diseases linked to obesity. The socio-economic i... ver más

01/12/2019

OSR

168K€

Presupuesto del proyecto: 168K€

Líder del proyecto

OSPEDALE SAN RAFFAELE SRL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-12-01

MSCA-IF-2016: Individual Fellowships

I+D

Cerrada hace 8 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

OSR

168.28K€ | Lider

Proyectos interesantes

EPIOBESITY

Medical Technol...

Data Science

161K€ Cerrado

SAF2017-84542-R

Medical Technol...

Data Science

145K€ Cerrado

PID2019-108175RB-I00

Medical Technol...

Data Science

363K€ Cerrado

EpiFAT

Medical Technol...

Data Science

2M€ Cerrado

OBEDIA-MARK

Medical Technol...

Data Science

243K€ Cerrado

BRITE

Medical Technol...

Data Science

2M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 32 meses Fecha Inicio: 2017-03-20
Fecha Fin: 2019-12-01

Líder del proyecto

OSPEDALE SAN RAFFAELE SRL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 168K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto It has been estimated a threefold increase in the number of obese people in Europe since the 1980’s. Currently, EU countries spend an average of 7% of their public health budgets on diseases linked to obesity. The socio-economic impact of obesity epidemic cannot be overrated. European societal needs require desperately a shift forward in the field of obesity research to be able to build new therapeutics strategies. Recent scientific evidences point toward a role of epigenetic changes as major contributor in the obesity etiology. In the last decades, a huge amount of data clearly link epigenetic dysregulation to obesity onset. Yet, it remains unclear whether epigenetic dysregulation contributes meaningfully to obesity epidemic. Because weight gain only occurs when energy intake exceed energy expenditure, burning off excess fuel represent an attractive path to reduce obesity when diet and exercise are not enough. My preliminary data indicate the histone methyltransferases Suv420h1 and Suv420h2 as pivotal players in metabolism regulation. By using knockout mice specifically in brown adipose tissue, this project aims at dissecting the role of Suv420h proteins in the etiology of obesity. I will combine in vivo and in vitro analyses and genome wide studies to: 1) dissect the role of Suv420h proteins in the epigenetic regulation of the pathways controlling weight balance in response to nutritional or environmental stimuli; 2) identify genes involved in the generation, maintenance or transmission of the epigenetic memory of exposure; 3) provide useful markers or therapeutic targets to treat obesity and metabolic diseases. My results have the potential to translate into therapeutics. This research will contribute to provide new clinical targets against obesity. The Experienced Researcher will emerge from the project with new skills, and the capability to lead her own research group.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores